Literature DB >> 6627946

Binding of the anti-progestin RU-486 to rat ovary steroid receptors.

J R Schreiber, A J Hsueh, E E Baulieu.   

Abstract

RU-486 is a recently synthesized steroid with anti-progesterone and anti-glucocorticoid properties. Its direct anti-progesterone action on the uterus is believed to be the basis for its ability to induce menstruation and early abortion. RU-486 likely antagonizes progesterone action on the uterus progesterone receptor. We have studied the binding of RU-486 to rat ovary steroid receptors in order to learn whether this interesting synthetic compound binds to ovary steroid receptors and thus learn if this antagonist can be used to better define the mechanism(s) of steroid actions on the ovary. Ovaries from estrogen stimulated hypophysectomized immature female rats were homogenized in buffer. The 100,000 x g supernatant was incubated with tritiated steroid agonists (R5020, dexamethasone, or testosterone) alone or with unlabeled steroids including RU-486. Receptor bound, and free steroid, were separated by Sephadex G-200 columns. The relative abilities of the various tested steroids to bind to the rat ovary progesterone receptor were: RU-486 greater than or equal to R5020 greater than progesterone. RU-486 bound to the ovary glucocorticoid receptor with an affinity equal to that of dexamethasone. The affinity of RU-486 for the rat ovary androgen receptor was only about 9% that of testosterone. Thus, RU-486 binds with very high affinity to the rat ovary progesterone and glucocorticoid receptors. This steroid receptor antagonist offers a new tool by which the mechanism(s) of action of these steroids on the ovary can be tested.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6627946     DOI: 10.1016/s0010-7824(83)80008-0

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  17 in total

1.  17β-estradiol and progesterone regulate expression of β-amyloid clearance factors in primary neuron cultures and female rat brain.

Authors:  Anusha Jayaraman; Jenna C Carroll; Todd E Morgan; Sharon Lin; Liqin Zhao; Jason M Arimoto; M Paul Murphy; Tina L Beckett; Caleb E Finch; Roberta Diaz Brinton; Christian J Pike
Journal:  Endocrinology       Date:  2012-09-07       Impact factor: 4.736

2.  Aldosterone Mediated Regulation of Epithelial Sodium Channel (ENaC) Subunits in the Rat Hypothalamus.

Authors:  Natalie J Mills; Kaustubh Sharma; Masudul Haque; Meagan Moore; Ryoichi Teruyama
Journal:  Neuroscience       Date:  2018-09-06       Impact factor: 3.590

Review 3.  Glucocorticoids and Reproduction: Traffic Control on the Road to Reproduction.

Authors:  Shannon Whirledge; John A Cidlowski
Journal:  Trends Endocrinol Metab       Date:  2017-03-06       Impact factor: 12.015

4.  Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations.

Authors:  John J Peluso; Jonathan Romak; Xiufang Liu
Journal:  Endocrinology       Date:  2007-11-08       Impact factor: 4.736

5.  Steroids initiate a signaling cascade that triggers rapid sporulation in Dictyostelium.

Authors:  Christophe Anjard; Yongxuan Su; William F Loomis
Journal:  Development       Date:  2009-01-28       Impact factor: 6.868

6.  Antiprogestagen RU486 prevents the LH-dependent decrease in the serum concentrations of inhibin in the rat.

Authors:  M Tébar; C Bellido; J T Uilenbroek; J E Sánchez-Criado
Journal:  Cell Mol Neurobiol       Date:  1996-06       Impact factor: 5.046

7.  Differential effects of synthetic progestagens on neuron survival and estrogen neuroprotection in cultured neurons.

Authors:  Anusha Jayaraman; Christian J Pike
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

8.  Inappropriate ovarian feedback in basal gonadotropin secretion in 4-day cyclic rat treated with mifepristone: role of endogenous estradiol.

Authors:  M Tébar; C Bellido; R Aguilar; J E Sánchez-Criado
Journal:  J Endocrinol Invest       Date:  1994-06       Impact factor: 4.256

9.  Selective cancer targeting via aberrant behavior of cancer cell-associated glucocorticoid receptor.

Authors:  Amarnath Mukherjee; Kumar P Narayan; Krishnendu Pal; Jerald M Kumar; Nandini Rangaraj; Shasi V Kalivendi; Rajkumar Banerjee
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

Review 10.  Mifegyne (mifepristone), a new antiprogestagen with potential therapeutic use in human fertility control.

Authors:  B Couzinet; G Schaison
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.